Clinical Trial Update: Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter [Phase 3]

View source ↗

Summary

Phase 3 trial studying dalteparin to prevent complications in cancer patients receiving chemotherapy via a catheter completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Myeloproliferative Disorders

Drugs mentioned

• Dalteparin (dalteparin)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Cervical Cancer, Chronic Myeloproliferative Disorders | Phase 3 | Status: COMPLETED